Literature DB >> 8760809

Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression.

N M Anstey1, J B Weinberg, M Y Hassanali, E D Mwaikambo, D Manyenga, M A Misukonis, D R Arnelle, D Hollis, M I McDonald, D L Granger.   

Abstract

Nitric oxide (NO)-related activity has been shown to be protective against Plasmodium falciparum in vitro. It has been hypothesized, however, that excess NO production contributes to the pathogenesis of cerebral malaria. The purpose of this study was to compare markers of NO production [urinary and plasma nitrate + nitrite (NOx)], leukocyte-inducible nitric oxide synthase type 2 (NOS2), and plasma TNF-alpha and IL-10 levels with disease severity in 191 Tanzanian children with and without malaria. Urine NOx excretion and plasma NOx levels (corrected for renal impairment) were inversely related to disease severity, with levels highest in subclinical infection and lowest in fatal cerebral malaria. Results could not be explained by differences in dietary nitrate ingestion among the groups. Plasma levels of IL-10, a cytokine known to suppress NO synthesis, increased with disease severity. Leukocyte NOS2 antigen was detectable in all control children tested and in all those with subclinical infection, but was undetectable in all but one subject with cerebral malaria. This suppression of NO synthesis in cerebral malaria may contribute to pathogenesis. In contrast, high fasting NOx levels and leukocyte NOS2 in healthy controls and asymptomatic infection suggest that increased NO synthesis might protect against clinical disease. NO appears to have a protective rather than pathological role in African children with malaria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760809      PMCID: PMC2192721          DOI: 10.1084/jem.184.2.557

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  52 in total

1.  Killing of Plasmodium falciparum in vitro by nitric oxide derivatives.

Authors:  K A Rockett; M M Awburn; W B Cowden; I A Clark
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Conversion of inhaled nitric oxide to nitrate in man.

Authors:  U N Westfelt; G Benthin; S Lundin; O Stenqvist; A Wennmalm
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

3.  Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria.

Authors:  R J Allan; P Beattie; C Bate; M B Van Hensbroek; S Morris-Jones; B M Greenwood; D Kwiatkowski
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

4.  IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism.

Authors:  S Mellouk; S J Green; C A Nacy; S L Hoffman
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

5.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05

6.  Magnetic resonance imaging of the brain in patients with cerebral malaria.

Authors:  S Looareesuwan; P Wilairatana; S Krishna; B Kendall; S Vannaphan; C Viravan; N J White
Journal:  Clin Infect Dis       Date:  1995-08       Impact factor: 9.079

7.  Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites.

Authors:  F W Klotz; L F Scheller; M C Seguin; N Kumar; M A Marletta; S J Green; A F Azad
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

8.  Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

Authors:  H B Peng; P Libby; J K Liao
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

9.  Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin.

Authors:  A K Nussler; M Di Silvio; T R Billiar; R A Hoffman; D A Geller; R Selby; J Madariaga; R L Simmons
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  136 in total

Review 1.  Nitric oxide and infectious diseases.

Authors:  D Burgner; K Rockett; D Kwiatkowski
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

2.  Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria.

Authors:  D J Perkins; P G Kremsner; D Schmid; M A Misukonis; M A Kelly; J B Weinberg
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice.

Authors:  B Nowicki; J Singhal; L Fang; S Nowicki; C Yallampalli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures.

Authors:  Yael Yuhas; Abraham Weizman; Shai Ashkenazi
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

5.  Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria.

Authors:  David Burgner; Stanley Usen; Kirk Rockett; Muminatou Jallow; Hans Ackerman; Alessandra Cervino; Margaret Pinder; Dominic P Kwiatkowski
Journal:  Hum Genet       Date:  2003-01-28       Impact factor: 4.132

6.  Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans.

Authors:  Louise M Randall; Enny Kenangalem; Daniel A Lampah; Emiliana Tjitra; Esther D Mwaikambo; Tjandra Handojo; Kim A Piera; Zhen Zhen Zhao; Fabian de Labastida Rivera; Yonghong Zhou; Karli M McSweeney; Lien Le; Fiona H Amante; Ashraful Haque; Amanda C Stanley; Tonia Woodberry; Ervi Salwati; Donald L Granger; Maurine R Hobbs; Ric N Price; J Brice Weinberg; Grant W Montgomery; Nicholas M Anstey; Christian R Engwerda
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

Review 7.  Cross-talk between nitric oxide and transforming growth factor-beta1 in malaria.

Authors:  Yoram Vodovotz; Ruben Zamora; Matthew J Lieber; Shirley Luckhart
Journal:  Curr Mol Med       Date:  2004-11       Impact factor: 2.222

8.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.

Authors:  Tsin W Yeo; Daniel A Lampah; Retno Gitawati; Emiliana Tjitra; Enny Kenangalem; Kim Piera; Ric N Price; Stephen B Duffull; David S Celermajer; Nicholas M Anstey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

Review 10.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.